Alder Biopharma (ALDR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -156,254 | -107,363 | -72,229 | -33,363 | -85,470 |
| Depreciation Amortization | 1,674 | 1,014 | 505 | 235 | 751 |
| Accounts receivable | N/A | N/A | N/A | N/A | 113 |
| Accounts payable and accrued liabilities | 5,488 | 968 | 2,851 | 4,921 | 2,816 |
| Other Working Capital | -18,606 | -10,931 | 2,345 | 2,810 | -2,670 |
| Other Operating Activity | 8,011 | 8,157 | 2,512 | -1,884 | 3,227 |
| Operating Cash Flow | $-159,687 | $-108,155 | $-64,016 | $-27,281 | $-81,233 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6,614 | -5,557 | -2,948 | -926 | -1,223 |
| Purchase Of Investment | -165,871 | -134,026 | -55,613 | -6,566 | -185,629 |
| Sale Of Investment | 104,765 | 75,695 | 10,250 | 6,250 | 19,585 |
| Investing Cash Flow | $-67,720 | $-63,888 | $-48,311 | $-1,242 | $-167,267 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 137,110 | 136,162 | 135,850 | 45 | 408,170 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 36 |
| Financing Cash Flow | $137,110 | $136,162 | $135,850 | $45 | $408,206 |
| Exchange Rate Effect | 21 | 21 | 21 | 21 | -9 |
| Beginning Cash Position | 206,492 | 206,492 | 206,492 | 206,492 | 46,795 |
| End Cash Position | 116,216 | 170,632 | 230,036 | 178,035 | 206,492 |
| Net Cash Flow | $-90,276 | $-35,860 | $23,544 | $-28,457 | $159,697 |
| Free Cash Flow | |||||
| Operating Cash Flow | -159,687 | -108,155 | -64,016 | -27,281 | -81,233 |
| Capital Expenditure | -6,619 | -5,562 | -2,953 | -931 | -1,223 |
| Free Cash Flow | -166,306 | -113,717 | -66,969 | -28,212 | -82,456 |